Table: Rion -2025/26 parent results
Table: Rion -2025/26 group results
Table: Rion - 9-MTH group results
Table: Rion - 6-MTH group results
Table: Rion -Q1 group results
Table: Rion -2024/25 group results
Table: Rion -2024/25 parent results
Brief: RION Announces First Patient Enrolled In Phase 1B Clinical Study Evaluating Purified Exosome Product For Knee Osteoarthritis
Table: Rion - 9-MTH group results
Brief: RION Initiation Of Phase 1b Clinical Study To Evaluate Purified Exosome Product (PEP) For Knee Osteoarthriti
Table: Rion -Q1 group results
Table: Rion -2023/24 group results
Table: Rion -2023/24 parent results
Table: Rion -2023/24 div forecast
Table: Rion - 9-MTH group results
Table: Rion - 6-MTH group results
2023 6-month group forecast
Table: Rion -Q1 group results
Table: Rion -2022/23 parent results